Onyx Biotec Limited — Updates, 08-04-2025: Press Release

Onyx Biotec Ltd. has entered into an agreement with Galpha Laboratories Limited for the manufacturing of Dry Powder Injection. Galpha Laboratories is recognized as a leading manufacturing and marketing company of pharmaceutical formulations. This collaboration underscores Onyx Biotec's commitment to maintaining global quality standards and compliance, with an aim to offer high-quality products at affordable prices.

The partnership is expected to enhance Onyx Biotec's production capacity and market offerings, which could positively impact its business growth trajectory. Investors should monitor this development closely, as it highlights the company’s strategic efforts to expand its product line and improve financial performance in the competitive pharmaceutical landscape.